Details
Stereochemistry | RACEMIC |
Molecular Formula | C27H31ClN2O |
Molecular Weight | 435.001 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CN2CCN(CCOC(C3=CC=CC=C3)C4=CC=CC=C4Cl)CC2)C=CC=C1
InChI
InChIKey=VEVSKUJZSMGTMM-UHFFFAOYSA-N
InChI=1S/C27H31ClN2O/c1-22-9-5-6-12-24(22)21-30-17-15-29(16-18-30)19-20-31-27(23-10-3-2-4-11-23)25-13-7-8-14-26(25)28/h2-14,27H,15-21H2,1H3
Molecular Formula | C27H31ClN2O |
Molecular Weight | 435.001 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Chlorbenzoxamine is an antimuscarinic agent used for the treatment of peptic ulcer disease and other functional gastrointestinal disorders. Chlorbenzoxamine, a structural analog of hydroxyzine, produces a unique antagonism of gastric ulceration induced in rats and dogs by various procedures. This effect is not accompanied by a significant gastric secretory depression or a reduction in gastric acid concentration. Chlorbenzoxamine does not show anticholinergic or antihistaminic activity in vitro but does produce a nonspecific depression of isolated smooth muscle. The antiulcer effect of chlorbenzoxamine in rats is abolished by hypophysectomy suggesting a central or endocrine mechanism of action.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:52:37 GMT 2023
by
admin
on
Sat Dec 16 15:52:37 GMT 2023
|
Record UNII |
N52918SLYN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QA03AX03
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
||
|
WHO-ATC |
A03AX03
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Chlorbenzoxamine
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
3090
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
N52918SLYN
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
DTXSID80862108
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
C79940
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
m3351
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | Merck Index | ||
|
208-323-0
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110781
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
71636
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
DB13788
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
806
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
522-18-9
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
100000081559
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY | |||
|
SUB06176MIG
Created by
admin on Sat Dec 16 15:52:38 GMT 2023 , Edited by admin on Sat Dec 16 15:52:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |